Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 2, 2019
Patent Application Number
15683999
Date Filed
August 23, 2017
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ANGPTL3 gene, as well as methods of inhibiting expression of ANGPTL3 and methods of treating subjects having a disorder of lipid metabolism, such as hyperlipidemia or hypertriglyceridemia, using such dsRNA compositions.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
